Irritable Bowel Syndrome
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome [Phase 3]
Phase 3 trial update for donor versus autologous fecal microbiota transplantation in irritable bowel syndrome.
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Optimization of Transcutaneous Electrical Acustimulation (TEA) Modalities for Treatment of IBS-C [NA]
Completed clinical trial evaluating transcutaneous electrical acustimulation modalities for treating irritable bowel syndrome with constipat…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Efficacy and Safety of Dietary Supplementation of Diamine Oxidase to Improve Symptoms in Patients With IBS [Phase 4]
A Phase 4 clinical trial is evaluating the efficacy and safety of dietary supplementation with diamine oxidase to improve symptoms in patien…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal Disorders [NA]
A terminated randomized sham-controlled pediatric trial evaluating auricular TENS stimulation for functional gastrointestinal disorders; res…
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas [Phase 4]
Phase 4 trial updating the effects of STW5 (Iberogast) and STW5-II (Iberogast N) on transit and tolerance of intestinal gas in IBS and funct…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-09-14FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic formulation of chlordiazepoxide hydrochloride and clidinium bromide from Aurobindo Pharma Limited under an Original A…
-
FDA approval · 2023-09-08FDA Approved: LOTRONEX — Supplemental Application (Legacy Pharma USA Inc.)
FDA approved a supplemental application for Lotronex (alosetron hydrochloride) from Legacy Pharma USA Inc., indicating an approval-related a…
-
FDA approval · 2023-09-08FDA Approved: ALOSETRON HYDROCHLORIDE — Supplemental Application (Eywa Pharma Inc)
FDA approves Eywa Pharma Inc's supplemental application for alosetron hydrochloride (ANDA211621).
-
FDA approval · 2023-08-30FDA Approved: DICYCLOMINE HYDROCHLORIDE — Original Application (Solco Healthcare US,LLC)
FDA approved the original generic application for dicyclomine hydrochloride from Solco Healthcare US, LLC.
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: TReatment of Irritable Bowel Syndrome With Diarrhoea Using Titrated ONdansetron Trial [Phase 3]
Phase 3 clinical trial update for ondansetron titration in irritable bowel syndrome with diarrhoea (IBS-D) has completed.
-
FDA approval · 2023-08-04FDA Approved: DICYCLOMINE HYDROCHLORIDE — Original Application (Bionpharma Inc.)
FDA approved a new generic version of dicyclomine hydrochloride from Bionpharma Inc. (ANDA 217916).
-
FDA approval · 2023-07-21FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for a generic combination of chlordiazepoxide hydrochloride and clidinium bromide from Amneal, enabl…
-
FDA approval · 2023-06-01FDA Approved: DICYCLOMINE HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved the original application for dicyclomine hydrochloride from Upsher-Smith Laboratories, LLC, a generic antispasmodic used to tre…
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Rifaximin Therapy vs Low FODMAP Diet In IBS [Phase 4]
A Phase 4 clinical trial comparing rifaximin therapy to a low FODMAP diet in irritable bowel syndrome and small intestinal bacterial overgro…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: Efficacy of a Probiotic Blend to Reduce Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome [Phase 2]
Phase 2 clinical trial evaluating a probiotic blend for reducing gastrointestinal symptoms in irritable bowel syndrome.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: The Efficacy and Safety of "BST104" (Lonicera Flos Extract) in Mild to Moderate Functional Dyspepsia Subjects [Phase 3]
Phase 3 trial assessing BST104 (Lonicera Flos Extract) for functional dyspepsia with completed status.
-
FDA approval · 2023-03-24FDA Approved: DICYCLOMINE HYDROCHLORIDE — Original Application (Solaris Pharma Corporation)
FDA approved the original application for dicyclomine hydrochloride (generic) from Solaris Pharma Corporation.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial [Phase 4]
A phase 4 multicenter trial studying peripheral histamine 1 receptor blockade for irritable bowel syndrome has completed.
-
FDA approval · 2023-01-13FDA Approved: LIBRAX — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for Librax (chlordiazepoxide hydrochloride and clidinium bromide) from Bausch Health US, LLC.
-
FDA approval · 2022-12-23FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for the combination drug chlordiazepoxide hydrochloride and clidinium bromide (brand name Librax) ma…
-
FDA approval · 2022-12-14FDA Approved: DICYCLOMINE HYDROCHLORIDE — Original Application (Trifluent Pharma, LLC)
FDA approved a generic dicyclomine hydrochloride product from Trifluent Pharma, LLC via its Original Application (ANDA 216736).
-
CLINICAL_TRIALS trial_result · 2022-12-07Clinical Trial Update: Saccharomyces Cerevisiae for Irritable Bowel Syndrome [Phase 1, Phase 2]
A clinical trial update for Saccharomyces cerevisiae conducted in Irritable Bowel Syndrome across Phase 1 and Phase 2 has completed.
-
FDA approval · 2022-11-28FDA Approved: DICYCLOMINE HYDROCHLORIDE — Original Application (Solaris Pharma Corporation)
FDA approved a generic version of dicyclomine hydrochloride under an Original Application (ANDA) for Solaris Pharma Corporation.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D) [Phase 2]
This trial update reports termination of the Phase 2 study of olorlinab for irritable bowel syndrome, including IBS with constipation and IB…
-
CLINICAL_TRIALS trial_result · 2022-09-13Clinical Trial Update: Rifaximin on Visceral Hypersensitivity [Phase 2]
A Phase 2 clinical trial evaluating rifaximin for visceral hypersensitivity and irritable bowel syndrome was terminated with results posted …